EDTA treatment is preferred to heparin treatment of whole blood for quantification of GSH in plasma Preparation Condition 1 (heparin deproteinization 80 o C) vs
Water, glycerin, BG, 3-glyceryl ascorbate, pentylene glycol, ascorbyl glucoside, trisodium ascorbyl palmitate phosphate, ascorbyl tetraisopalmitate, niacinamide, fullerene, ascorbic acid, dipotassium glycyrrhizinate, hydrolyzed collagen, squalane, sodium hyaluronate, ceramide NP, ceramide AP, ceramide NG, yeast extract, centella asiatica extract, tocopherol, sucrose stearate, agar, caprylyl Glycol, 1,2-Hexanediol, Xanthophyll, Caprylic/Capric Triglyceride, Hydroxypropyl Starch Phosphate, Hydroxyethylcellulose, Ethylhexylglycerin, PVP, Sodium Hydroxide, Hydroxyacetophenone, Pentasodium Pentetate, Acrylates/C10-30 Alkyl Acrylate Crosspolymer, Polyacrylate Crosspolymer-6, PPG-6 Decyltetradeceth-30, Sodium PCA, Phenoxyethanol
For research-supply positioning, this question should be reframed around experimental protocol design rather than use instructions
Product Name: BPC-157 Strength: 20mg Chemical Name: Body Protection Compound-157 CAS Number: 137525-51-0 Molecular Formula: CHNO Molecular Weight: 1419.56 g/mol Amino Acid Sequence: Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val Appearance: White to Off-White Lyophilized Powder Classification: Synthetic Pentadecapeptide Purity: Verified by analytical testing prior to release Analytical Methods: HPLC, Mass Spectrometry (MS) Research areas commonly associated with this compound include: Tissue Repair Healing & Inflammation Store lyophilized material refrigerated at 28C for routine storage